Non-alcoholic fatty liver disease (
NAFLD) is the most common liver disorder with intricate etiology. It is closely associated with
metabolic syndrome,
insulin resistance and endoplasmic reticulum (ER) stress. Exostosin1 (Ext1) is an ER-resident transmembrane
glycosyltransferase, which plays an important role in ER homeostasis. Loss-of-function mutations in Ext1 link to
hereditary multiple exostosis (HME). The present research was undertaken to identify the effect of Ext1 in the progress of
NAFLD. High-fat-diet induced mice
obesity, hepatic steatosis and decreased hepatic Ext1 expression. In consistent with evaluation of
NAFLD mice possessing down-regulated Ext1 expression,
free fatty acid (FFA) treatment blunted Ext1 expression in hepatocytes. In human subjects, HME patients presented elevated fasting
blood glucose-one of the criteria that define
insulin resistance. In vitro experiments, Ext1 deficiency promoted FFA-induced
insulin resistance in hepatocytes by analysis of
glycogen storage and hallmarks of gluconeogenesis, ascertaining its association with
insulin resistance. Mechanically, Ext1 silencing exacerbated ER stress triggered by FFA, which severely disrupted autophagy in hepatocytes, and thereby accelerated the progression of
NAFLD. In conclusion, our study demonstrates a beneficial role for Ext1 during the development of
NAFLD, which establishes a novel correlation between Ext1 and ER stress-induced perturbations of autophagy during
NAFLD progression.